HALOZYME THERAPEUTICS, INC. (HALO) Gross profit 2016–2025
HALOZYME THERAPEUTICS, INC. (HALO) annual gross profit history from SEC filings — each fiscal year as reported.
$1.2BFY2025 · since FY2016: $113.5M → $1.2B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $1.2B | +36.4% |
| FY2024 | $855.9M | +34.4% |
| FY2023 | $636.9M | +22.3% |
| FY2022 | $520.8M | +43.9% |
| FY2021 | $361.9M | +61.4% |
| FY2020 | $224.2M | +49.0% |
| FY2019 | $150.4M | +6.2% |
| FY2018 | $141.7M | -50.4% |
| FY2017 | $285.5M | +151.5% |
| FY2016 | $113.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice